{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:45:20Z","timestamp":1760244320763,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajoc.2025.102325","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:23:14Z","timestamp":1744150994000},"page":"102325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\u201cOptic nerve of steel\u201d: A case of very high intraocular pressures with markedly little visual field progression over years"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5815-9283","authenticated-orcid":false,"given":"Yixi","family":"Xue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5902-4168","authenticated-orcid":false,"given":"Milica A.","family":"Margeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ajoc.2025.102325_bib1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102325_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ajo.2011.06.004","article-title":"An assessment of the health and economic burdens of glaucoma","volume":"152","author":"Varma","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102325_bib3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102325_bib4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2025.102325_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaophthalmol.2021.0341","article-title":"Assessment of cumulative incidence and severity of primary open-angle glaucoma among participants in the ocular hypertension treatment study after 20 Years of follow-up","volume":"139","author":"Kass","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102325_bib6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2025.102325_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0039-6257(00)00110-7","article-title":"Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach","volume":"44","author":"Doughty","year":"2000","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102325_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41433-022-02026-1","article-title":"Central corneal thickness and its associations in a Russian population. The Ural eye and Medical Study","volume":"37","author":"Bikbov","year":"2023","journal-title":"Eye (Lond)."},{"issue":"5","key":"10.1016\/j.ajoc.2025.102325_bib9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41433-018-0033-3","article-title":"The thick and thin of the central corneal thickness in glaucoma","volume":"32","author":"Belovay","year":"2018","journal-title":"Eye (Lond)."},{"issue":"1","key":"10.1016\/j.ajoc.2025.102325_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ophtha.2006.08.031","article-title":"Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension","volume":"114","author":"Ocular Hypertension Treatment Study","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2025.102325_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5288726","article-title":"A novel, low-cost glaucoma calculator to identify glaucoma patients and stratify management","volume":"2022","author":"Laroche","year":"2022","journal-title":"J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2025.102325_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ejhg.2010.11","article-title":"LTBP2 null mutations in an autosomal recessive ocular syndrome with megalocornea, spherophakia, and secondary glaucoma","volume":"18","author":"Desir","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ajoc.2025.102325_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.pharmtox.48.061807.154729","article-title":"Role of CYP1B1 in glaucoma","volume":"48","author":"Vasiliou","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.ajoc.2025.102325_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s10038-022-01115-z","article-title":"A new association of PAX6 variation with Juvenile onset open angle glaucoma","volume":"68","author":"Gupta","year":"2023","journal-title":"J Hum Genet"},{"issue":"8","key":"10.1016\/j.ajoc.2025.102325_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.61.8.3","article-title":"Association of APOE with primary open-angle glaucoma suggests a protective effect for APOE epsilon4","volume":"61","author":"Margeta","year":"2020","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajoc.2025.102325_bib16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41588-023-01428-5","article-title":"Large-scale multitrait genome-wide association analyses identify hundreds of glaucoma risk loci","volume":"55","author":"Han","year":"2023","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102325_bib17","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.2353\/ajpath.2006.060400","article-title":"Studies of optineurin, a glaucoma gene: golgi fragmentation and cell death from overexpression of wild-type and mutant optineurin in two ocular cell types","volume":"169","author":"Park","year":"2006","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.ajoc.2025.102325_bib18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ng.824","article-title":"Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1","volume":"43","author":"Burdon","year":"2011","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.ajoc.2025.102325_bib19","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.ophtha.2016.08.036","article-title":"Glaucoma risk alleles in the ocular hypertension treatment study","volume":"123","author":"Scheetz","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2025.102325_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.exer.2018.11.005","article-title":"All roads lead to glaucoma: induced retinal injury cascades contribute to a common neurodegenerative outcome","volume":"183","author":"Alqawlaq","year":"2019","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102325_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.exer.2010.05.016","article-title":"Neurotrophic factor delivery as a protective treatment for glaucoma","volume":"93","author":"Johnson","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajoc.2025.102325_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fnins.2017.00146","article-title":"Metabolic vulnerability in the neurodegenerative disease glaucoma","volume":"11","author":"Inman","year":"2017","journal-title":"Front Neurosci"},{"issue":"6326","key":"10.1016\/j.ajoc.2025.102325_bib23","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1126\/science.aal0092","article-title":"Vitamin B(3) modulates mitochondrial vulnerability and prevents glaucoma in aged mice","volume":"355","author":"Williams","year":"2017","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ajoc.2025.102325_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/ceo.13818","article-title":"Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial","volume":"48","author":"Hui","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102325_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamaophthalmol.2021.4576","article-title":"Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: a phase 2 randomized clinical trial","volume":"140","author":"De Moraes","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2025.102325_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100310","article-title":"Association between HSP-specific T-cell counts and retinal nerve fiber layer thickness in patients with primary open-angle glaucoma","volume":"3","author":"Saini","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102325_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12974-024-03035-5","article-title":"Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner","volume":"21","author":"He","year":"2024","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102325_bib28","first-page":"143","article-title":"The role of microglia in the progression of glaucomatous neurodegeneration- a review","volume":"11","author":"Zeng","year":"2018","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2025.102325_bib29","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.ajoc.2025.102325_bib30","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.immuni.2022.07.014","article-title":"Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma","volume":"55","author":"Margeta","year":"2022","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.ajoc.2025.102325_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.11.11.1","article-title":"Neurodegeneration markers galectin-3 and Apolipoprotein E are elevated in the aqueous humor of eyes with glaucoma","volume":"11","author":"Pitts","year":"2022","journal-title":"Transl Vis Sci Technol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:27:37Z","timestamp":1760146057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993625000787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":31,"alternative-id":["S2451993625000787"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102325","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cOptic nerve of steel\u201d: A case of very high intraocular pressures with markedly little visual field progression over years","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102325"}}